tirzepatide fda news confirms shortage is still over, gives compounders a grace period Today the FDA issued its

Join the thousands who have discovered the benefits of personalized health and wellness services

Key Takeaways: What Women Need to Know About CJC-1295/Ipamorelin Growth hormone production starts declining at 35, not at menopause

Each form offers unique benefits and challenges

Understanding the GLP-1 consumer The GLP-1 era has given rise to multiple distinct consumer types, each with shared, yet nuanced, nutritional needs: Consumers currently using GLP-1 therapies face unique challenges, including appetite suppression that can make meeting nutritional requirements difficult, potential gastrointestinal side effects and concerns about maintaining muscle mass during weight loss

If you notice any of these, contact your healthcare provider the same day: Pus, warmth spreading from the site, or fever signs of skin infection (cellulitis)